Xellia Pharms Aps Company Profile
✉ Email this page to a colleague
What is the competitive landscape for XELLIA PHARMS APS, and when can generic versions of XELLIA PHARMS APS drugs launch?
XELLIA PHARMS APS has sixteen approved drugs.
There are seven US patents protecting XELLIA PHARMS APS drugs.
There are fifty patent family members on XELLIA PHARMS APS drugs in thirty countries and twenty-eight supplementary protection certificates in nine countries.
Summary for Xellia Pharms Aps
International Patents: | 50 |
US Patents: | 7 |
Tradenames: | 10 |
Ingredients: | 10 |
NDAs: | 16 |
Drugs and US Patents for Xellia Pharms Aps
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xellia Pharms Aps | VANCOMYCIN | vancomycin | SOLUTION;INTRAVENOUS, ORAL | 213895-001 | Aug 26, 2021 | DISCN | Yes | No | 10,849,956 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Xellia Pharms Aps | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 091377-001 | Sep 9, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Xellia Pharms Aps | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | SOLUTION;INTRAVENOUS | 211962-005 | May 13, 2020 | RX | Yes | Yes | 10,188,697 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Xellia Pharms Aps Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Costa Rica | 20170234 | ⤷ Sign Up |
South Africa | 201702767 | ⤷ Sign Up |
Cyprus | 1122960 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Xellia Pharms Aps Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0440372 | SPC/GB02/031 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: VORICONAZOLE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/02/212/001-025 20020319 |
0440372 | 02C0030 | France | ⤷ Sign Up | PRODUCT NAME: VORICONAZOLE; NAT. REGISTRATION NO/DATE: EU/1/02/212/001-025 20020319; FIRST REGISTRATION: EU/1/02/212/001-25 20020319 |
1280520 | C300722 | Netherlands | ⤷ Sign Up | PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.